Glaxo’s Vaccines Chairman Moncef Slaoui to Retire Next Year
Slaoui to leave board in March, remain as adviser until July
Debruyne to continue to run Glaxo’s vaccine business
GlaxoSmithKline Plc’s vaccines division chief, Moncef Slaoui, will retire next year after a nearly 30-year career at the U.K.’s biggest drugmaker.
Slaoui will remain a member of the board until March 31, and leave the company on June 30, 2017, the London-based company said in a statement on Tuesday. Slaoui joined Glaxo in 1988 and became a director in 2006.